Back
TransCode Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6
RNAZ
TransCode Therapeutics, Inc.
Last Price:
$7.31
Seasonality Move:
-51.12%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAZ is experiencing slight buying pressure.
TransCode Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.37 | Sell |
| 20-day SMA: | 8.72 | Sell |
| 50-day SMA: | 10.16 | Sell |
| 200-day SMA: | 10.9 | Sell |
| 8-day EMA: | 5.54 | Buy |
| 20-day EMA: | 3.07 | Buy |
| 50-day EMA: | 1.42 | Buy |
| 200-day EMA: | 0.38 | Buy |
TransCode Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.91 | Buy |
| Relative Strength Index (14 RSI): | 35 | Sell |
| Chaikin Money Flow: | 528 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.11 - 9.37) | Sell |
| Bollinger Bands (100): | (8.8 - 12.38) | Sell |
TransCode Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for TransCode Therapeutics, Inc. Stock
Is TransCode Therapeutics, Inc. Stock a Buy?
-
TransCode Therapeutics, Inc. share price is 7.43 while RNAZ 8-day simple moving average is 8.37, which is a Sell signal.
-
The stock price of RNAZ is 7.43 while TransCode Therapeutics, Inc. 20-day SMA is 8.72, which makes it a Sell.
-
TransCode Therapeutics, Inc. 50-day simple moving average is 10.16 while RNAZ share price is 7.43, making it a Sell technically.
-
RNAZ stock price is 7.43 and TransCode Therapeutics, Inc. 200-day simple moving average is 10.90, creating a Sell signal.
RNAZ Technical Analysis vs Fundamental Analysis
Sell
6
TransCode Therapeutics, Inc. (RNAZ)
is a Sell
Is TransCode Therapeutics, Inc. a Buy or a Sell?
-
TransCode Therapeutics, Inc. stock is rated a SellThe current TransCode Therapeutics, Inc. [RNAZ] share price is $7.43. The Score for RNAZ is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
TransCode Therapeutics, Inc. Stock Info
Market Cap:
6.2M
Price in USD:
7.43
Share Volume:
5.6K
TransCode Therapeutics, Inc. 52-Week Range
52-Week High:
468.44
52-Week Low:
6.15
Sell
6
TransCode Therapeutics, Inc. (RNAZ)
is a Sell
TransCode Therapeutics, Inc. Share Price Forecast
-
What is the TransCode Therapeutics, Inc. stock price today?The TransCode Therapeutics, Inc. stock price is 7.43 USD today.
-
Will RNAZ stock go up or go down?TransCode Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is TransCode Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, TransCode Therapeutics, Inc. is overvalued.
Is TransCode Therapeutics, Inc. Stock a Buy?
-
TransCode Therapeutics, Inc. share price is 7.43 while RNAZ 8-day exponential moving average is 5.54, which is a Buy signal.
-
The stock price of RNAZ is 7.43 while TransCode Therapeutics, Inc. 20-day EMA is 3.07, which makes it a Buy.
-
TransCode Therapeutics, Inc. 50-day exponential moving average is 1.42 while RNAZ share price is 7.43, making it a Buy technically.
-
RNAZ stock price is 7.43 and TransCode Therapeutics, Inc. 200-day simple moving average is 0.38, creating a Buy signal.
Fundamental Analysis of TransCode Therapeutics, Inc.
Is TransCode Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $131.65 per share, and an increase next year of $1.31 per share.
Technical Analysis of TransCode Therapeutics, Inc.
Should I short TransCode Therapeutics, Inc. stock?
-
RNAZ Moving Average Covergence Divergence (MACD) indicator is 1.91, suggesting TransCode Therapeutics, Inc. is a Buy
-
TransCode Therapeutics, Inc. Relative Strength Index (RSI) is 35, which suggest TransCode Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for TransCode Therapeutics, Inc. is (8.11 - 9.37), which suggest TransCode Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for TransCode Therapeutics, Inc. is (8.8 - 12.38), which suggest TransCode Therapeutics, Inc. is a Sell
* TransCode Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.